Neuroprotective and disease-modifying effects of the ketogenic diet

Behavioural Pharmacology

Volumn 17, Issue 5-6, 2006, Pages 431-439

  Gasior, Maciej ^a   Rogawski, Michael A ^a   Hartman, Adam L ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Cellular energetics; Epilepsy; Ketogenic diet; Ketone bodies; Mitochondria; Neuroprotection; Parkinson's disease; Stroke; Traumatic brain injury

Indexed keywords

4 AMINOBUTYRIC ACID; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN ISCHEMIA; DIET RESTRICTION; DIET THERAPY; ENERGY METABOLISM; EPILEPSY; HUMAN; KETOGENIC DIET; MEMORY; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW; RISK REDUCTION; STROKE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL SURVIVAL; DIET, CARBOHYDRATE-RESTRICTED; DIETARY FATS; HUMANS; KETONE BODIES; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 33748298884     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200609000-00009     Document Type: Review

References (114)

1. Acheson KJ (2004). Carbohydrate and weight control: where do we stand? Curr Opin Clin Nutr Metab Care 7:485-492.
2. al-Mudallal AS, LaManna JC, Lust WD, Harik SI (1996). Diet-induced ketosis does not cause cerebral acidosis. Epilepsia 37:258-261.
3. Appleton DB, De Vivo DC (1973). An experimental animal model for the effect of ketogenic diet on epilepsy. Proc Aust Assoc Neurol 10:75-80.
4. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S (2002). Fish, meat, and risk of dementia: cohort study. BMJ 325:932-933.
5. Bellido T, Huening M, Raval-Pandya M, Manolagas SC, Christakos S (2000). Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J Biol Chem 275:26328-26332.
6. Benardo LS (2003). Prevention of epilepsy after head trauma: do we need new drugs or a new approach? Epilepsia 44(Suppl 10):27-33.
7. Bough KJ, Gudi K, Han FT, Rathod AH, Eagles DA (2002). An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Res 50:313-325.
8. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, et al. (2006). Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol (60).
9. Cahill GF Jr, Veech RL (2003). Ketoacids? Good medicine? Trans Am Clin Climatol Assoc 114:149-161.
10. Caraballo RH, Cersosimo RO, Sakr D, Cresta A, Escobal N, Fejerman N (2005). Ketogenic diet in patients with Dravet syndrome. Epilepsia 46:1539-1544.
11. Chamorro A, Hallenbeck J (2006). The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37:291-293.
12. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH, Simon RP (1998). Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18:4914-4928.
13. Cherian L, Peek K, Robertson CS, Goodman JC, Grossman RG (1994). Calorie sources and recovery from central nervous system ischemia. Crit Care Med 22:1841-1850.
14. Ciraolo ST, Previs SF, Fernandez CA, Agarwal KC, David F, Koshy J, et al. (1995). Model of extreme hypoglycemia in dogs made ketotic with (R,S)-1, 3-butanediol acetoacetate esters. Am J Physiol 269:E67-E75.
15. Crumrine PK (2002). Lennox-Gastaut syndrome. J Child Neurol 17(Suppl 1):S70-S75.
16. Cullingford TE (2004). The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 70:253-264.
17. Cunnane SC, Musa K, Ryan MA, Whiting S, Fraser DD (2002). Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukot Essent Fatty Acids 67:131-135.
18. Dardzinski BJ, Smith SL, Towfighi J, Williams GD, Vannucci RC, Smith MB (2000). Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment. Pediatr Res 48:248-255.
19. Desrochers S, David F, Garneau M, Jetté M, Brunengraber H (1992). Metabolism of R- and S-1,3-butanediol in perfused livers from meal-fed and starved rats. Biochem J 285:647-653.
20. Desrochers S, Dubreuil P, Brunet J, Jetté M, David F, Landau BR, Brunengraber H (1995). Metabolism of (R,S)-1,3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs. Am J Physiol 268:E660-E667.
21. de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM (2005). Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 64:2040-2045.
22. Duan W, Mattson MP (1999). Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res 57:195-206.
23. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002). Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology 59:1915-1921.
24. Erecinska M, Nelson D, Daikhin Y, Yudkoff M (1996). Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J Neurochem 67:2325-2334.
25. Fraser DD, Whiting S, Andrew RD, Macdonald EA, Musa-Veloso K, Cunnane SC (2003). Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60:1026-1029.
26. Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E (2006). The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 68:145-180.
27. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM (1998). The efficacy of the ketogenic diet - 1998: a prospective evaluation of intervention in 150 children. Pediatrics 102:1358-1363.
28. Fujikawa DG (2005). Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav 7(Suppl 3):S3-S11.
29. Garcia O, Massieu L (2001). Strategies for neuroprotection against L-trans-2, 4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro. J Neurosci Res 64:418-428.
30. George AJ, Holsinger RMD, McLean CA, Laughton KM, Beyreuther K, Evin G, et al. (2004). APP intracellular domain is increased and soluble A β is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease. Neurobiol Dis 16:124-132.
31. Gillardon F, Bottiger B, Schmitz B, Zimmermann M, Hossmann KA (1997). Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy. Brain Res Mol Brain Res 50:16-22.
32. Grant WB (1999). Dietary links to Alzheimer's disease: 1999 update. J Alzheimers Dis 1:197-201.
33. Greene AE, Todorova MT, McGowan R, Seyfried TN (2001). Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 42:1371-1378.
34. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, et al. (2002). Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81:1084-1091.
35. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O (2005). Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β-infused rats. J Nutr 135:549-555.
36. Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. (2001). The ketogenic diet: a 3- to 6- year follow-up of 150 children enrolled prospectively. Pediatrics 108:898-905.
37. Henderson ST (2004). High carbohydrate diets and Alzheimer's disease. Med Hypotheses 62:689-700.
38. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, et al. (2004). Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18:902-904.
39. Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK (2005). Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Synapse 57:100-112.
40. Hori A, Tandon P, Holmes GL, Stafstrom CE (1997). Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia 38:750-758.
41. Huttenlocher PR (1976). Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 10:536-540.
42. Huttenlocher PR, Wilbourn AJ, Signore JM (1971). Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 21:1097-1103.
43. Jones SE, Jomary C (2002). Clusterin. Int J Biochem Cell Biol 34:427-431.
44. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM (1997). Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42:776-782.
45. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL (2000). D-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 97:5440-5444.
46. Kossoff EH (2004). More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol 3:415-420.
47. Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP (2006). A modified atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 47:421-424.
48. Lee J, Bruce-Keller AJ, Kruman Y, Chan SL, Mattson MP (1999). 2-Deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J Neurosci Res 57:48-61.
49. Lee J, Kim SJ, Son TG, Chan SL, Mattson MP (2006). Interferon-gamma is upregulated in the hippocampus in response to intermittent fasting and protects hippocampal neurons against excitotoxicity. J Neurosci Res 83:1552-1557.
50. Levin-Allerhand JA, Lominska CE, Smith JD (2002). Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J Nutr Health Aging 6:315-319.
51. Likhodii SS, Musa K, Mendonca A, Dell C, Burnham WM, Cunnane SC (2000). Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia 41:1400-1410.
52. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. (2005). A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032-3040.
53. Mantis JG, Centeno NA, Todorova MT, McGowan R, Seyfried TN (2004). Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr Metab (London) 1:11.
54. Marie C, Bralet AM, Gueldry S, Bralet J (1990). Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis. Metab Brain Dis 5:65-75.
55. Marsh EB, Freeman JM, Kossoff EH, Vining EP, Rubenstein JE, Pyzik PL, Hemingway C (2006). The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. Epilepsia 47:425-430.
56. Massieu L, Del RP, Montiel T (2001). Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 106:669-677.
57. Massieu L, Haces ML, Montiel T, Hernandez-Fonseca K (2003). Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120:365-378.
58. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, et al. (2004). Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci USA 101:18171-18176.
59. Mattson MP, Cheng B, Baldwin SA, Smith-Swintosky VL, Keller J, Geddes JW, et al. (1995). Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J Neurosci Res 42:357-370.
60. McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, Lee VM, Trojanowski JQ (1998). The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol 24:251-267.
61. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. (2003a). Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60:194-200.
62. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. (2003b). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60:940-946.
63. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS (2004). Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 62:1573-1579.
64. Muller-Schwarze AB, Tandon P, Liu Z, Yang Y, Holmes GL, Stafstrom CE (1999). Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 10:1517-1522.
65. Musa-Veloso K, Likhodii SS, Cunnane SC (2002). Breath acetone is a reliable indicator of ketosis in adults consuming ketogenic meals. Am J Clin Nutr 76:65-70.
66. Nehlig A (2004). Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot Essent Fatty Acids 70:265-275.
67. Neuroinflammation Working Group (2000). Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
68. Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, et al. (2003). The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 53:119-128.
69. Noh HS, Kang SS, Kim DW, Kim YH, Park CH, Han JY, et al. (2005a). Ketogenic diet increases calbindin-D28k in the hippocampi of male ICR mice with kainic acid seizures. Epilepsy Res 65:153-159.
70. Noh HS, Kim DW, Kang SS, Cho GJ, Choi WS (2005b). Ketogenic diet prevents clusterin accumulation induced by kainic acid in the hippocampus of male ICR mice. Brain Res 1042:114-118.
71. Noh HS, Hah YS, Nilufar R, Han J, Bong JH, Kang SS, et al. (2006). Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res 83:702-709.
72. Palmblad J, Hafstrom I, Ringertz B (1991). Antirheumatic effects of fasting. Rheum Dis Clin North Am 17:351-362.
73. 13C2]-β-Hydroxybutyrate metabolism in human brain. J Cereb Blood Flow Metab 22:890-898.
74. Patel NV, Gordon MN, Connor KE, Good RA, Engelman RW, Mason J, et al. (2005). Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models. Neurobiol Aging 26:995-1000.
75. Pierre K, Pellerin L (2005). Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94:1-14.
76. Pratico D, Trojanowski JQ (2000). Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 21:441-445.
77. Prins ML, Lee SM, Fujima LS, Hovda DA (2004). Increased cerebral uptake and oxidation of exogenous bHB improves ATP following traumatic brain injury in adult rats. J Neurochem 90:666-672.
78. Prins ML, Fujima LS, Hovda DA (2005). Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res 82:413-420.
79. Rafiki A, Boulland JL, Halestrap AP, Ottersen OP, Bergersen L (2003). Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain. Neuroscience 122:677-688.
80. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. (2004). Effects of β-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25:311-314.
81. Rho JM, Anderson GD, Donevan SD, White HS (2002). Acetoacetate, acetone, and dibenzylamine (a contaminant in L-(+)-β-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43:358-361.
82. Ruitenberg A, Kalmijn S, de Ridder MA, Redekop WK, van HF, Hofman A, et al. (2001). Prognosis of Alzheimer's disease: the Rotterdam Study. Neuroepidemiology 20:188-195.
83. Schachter SC (2002). Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic. Epilepsy Res 50:67-70.
84. Schwartz RH, Eaton J, Bower BD, ynsley-Green A (1989). Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol 31:145-151.
85. Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC (2002). Diet-induced hypercholesterolemia enhances brain Ab accumulation in transgenic mice. Neuroreport 13:455-459.
86. Sinha SR, Kossoff EH (2005). The ketogenic diet. Neurologist 11:161-170.
87. Smith SL, Heal DJ, Martin KF (2005). KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Rev 11:113-140.
88. Stafstrom CE (1999). Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res 37:241-259.
89. Stafstrom CE (2004). Dietary approaches to epilepsy treatment: old and new options on the menu. Epilepsy Curr 4:215-222.
90. Stafstrom CE, Wang C, Jensen FE (1999). Electrophysiological observations in hippocampal slices from rats treated with the ketogenic diet. Dev Neurosci 21:393-399.
91. Stamp LK, James MJ, Cleland LG (2005). Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 35:77-94.
92. Su SW, Cilio MR, Sogawa Y, Silveira DC, Holmes GL, Stafstrom CE (2000). Timing of ketogenic diet initiation in an experimental epilepsy model. Brain Res Dev Brain Res 125:131-138.
93. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM (2004). The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 55:576-580.
94. Suzuki M, Suzuki M, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A (2001). Effect of β-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol 87:143-150.
95. Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, et al. (2002). β-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol 89:36-43.
96. Thavendiranathan P, Mendonca A, Dell C, Likhodii SS, Musa K, Iracleous C, et al. (2000). The MCT ketogenic diet: effects on animal seizure models. Exp Neurol 161:696-703.
97. Thavendiranathan P, Chow C, Cunnane S, McIntyre BW (2003). The effect of the 'classic' ketogenic diet on animal seizure models. Brain Res 959:206-213.
98. Tieu K, Perier C, Caspersen C, Teismann P, Wu DC, Yan SD, et al. (2003). D-β-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 112:892-901.
99. Todorova MT, Tandon P, Madore RA, Stafstrom CE, Seyfried TN (2000). The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 41:933-940.
100. Trevathan E (2002). Infantile spasms and Lennox-Gastaut syndrome. J Child Neurol 17 (Suppl 2):2S9-2S22.
101. Van der Auwera I, Wera S, Van LF, Henderson ST (2005). A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (London) 2:28.
102. VanItallie TB, Nonas C, Di RA, Boyar K, Hyams K, Heymsfield SB (2005). Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 64:728-730.
103. Vannucci SJ, Simpson IA (2003). Developmental switch in brain nutrient transporter expression in the rat. Am J Physiol Endocrinol Metab 285:E1127-E1134.
104. Veech RL (2004). The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70:309-319.
105. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. (2001). Ketone bodies, potential therapeutic uses. IUBMB Life 51:241-247.
106. Vezzani A, Granata T (2005). Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:1724-1743.
107. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, et al. (1998). A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 55:1433-1437.
108. Wang ZJ, Bergqvist C, Hunter JV, Jin D, Wang DJ, Wehrli S, Zimmerman RA (2003). In vivo measurement of brain metabolites using two-dimensional double-quantum MR spectroscopy: exploration of GABA levels in a ketogenic diet. Magn Reson Med 49:615-619.
109. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, et al. (2005). Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 19:659-661.
110. Wilder RM (1921). The effects of ketonemia on the course of epilepsy. Mayo Clin Proc 2:307-308.
111. Yamada KA, Rensing N, Thio LL (2005). Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neurosci Lett 385:210-214.
112. Young KW, Greenwood CE, van RR, Binns MA (2005). A randomized, crossover trial of high-carbohydrate foods in nursing home residents with Alzheimer's disease: associations among intervention response, body mass index, and behavioral and cognitive function. J Gerontol A Biol Sci Med Sci 60:1039-1045.
113. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I (2001). Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 66:931-940.
114. Ziegler DR, Ribeiro LC, Hagenn M, Siqueira IR, Araujo E, Torres IL, et al. (2003). Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem Res 28:1793-1797.